Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine for Remifentanil-Induced Postoperative Hyperalgesia
NCT07913555Phase 4Completed
- Start
- May 2026
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
A Phase 4 trial of oliceridine in Postoperative hyperalgesia. Started May 2026; status: completed.
02
Drugs
oliceridine
03
Conditions
Postoperative hyperalgesia
Beyond the preview
Go deeper on NCT07913555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07913555.